ÂÜÀòÂÒÂ×

Kristina Thaben is an experienced professional in the field of pulmonary arterial hypertension (PAH), currently serving as a PAH-Manager at betapharm Arzneimittel GmbH since 2019. Prior to this role, Kristina held several positions at OMT GmbH & Co. KG from February 2012 to June 2017, including MSL-Pharma, where responsibilities included managing the portfolio for PAH, leading the sales team for parenteral treprostinil therapy, and overseeing PAH support functions. Kristina also served as Regionalleitung for infusion therapy, neuromodulation, and PAH. Kristina Thaben holds a Diplom Biologin degree with a focus on immunology and medical research from The University of Bonn.